AP
NVO

Aspect Partners’s Novo Nordisk NVO Stock Holding History

Aspect Partners’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.96K Buy
166
+6
+4% +$258 ﹤0.01% 330
2026
Q1 		$5.88K Buy
160
+15
+10% +$711 ﹤0.01% 338
2025
Q4 		$7.38K Buy
145
+12
+9% +$614 ﹤0.01% 314
2025
Q3 		$7.38K Buy
133
+70
+111% +$4.1K ﹤0.01% 354
2025
Q2 		$4.35K Buy
63
+39
+163% +$2.65K ﹤0.01% 387
2025
Q1 		$1.67K Buy
24
+19
+380% +$1.57K ﹤0.01% 466
2024
Q4 		$429 Buy
+5
New +$541 ﹤0.01% 561

Other funds holding NVO

SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
OFA
Oak Family Advisors Chicago, Illinois $391M AUM 26.35% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Aspect Partners's NVO Position: Q2 2026 in Review

Aspect Partners increased its Novo Nordisk (NVO) stake by 3.8% in Q2 2026, buying an estimated $258 and bringing the position to 166 shares worth $7.96K. The position accounts for ﹤0.01% of the portfolio, ranked #330.

Aspect Partners first reported a position in NVO in Q4 2024 and has held it in 7 quarters since. 383 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Aspect Partners held 166 shares of Novo Nordisk worth $7.96K as of Q2 2026.
  • Aspect Partners bought 6 Novo Nordisk shares in Q2 2026, an estimated $258.
  • Novo Nordisk made up ﹤0.01% of Aspect Partners's portfolio in Q2 2026, its #330 holding.
  • Aspect Partners first reported a position in Novo Nordisk in Q4 2024 and has held it in 7 quarters since.
  • 383 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Aspect Partners's 13F filing for Q2 2026, filed 16 Jul 2026.